Efavirenz Therapeutic Range in HIV-1 Treatment Naïve Participants

OBJECTIVES: Efavirenz is currently suggested as an alternative to recommended antiretroviral (ARV) regimens by the Department of Health and Human Services for the treatment of HIV-1 in ARV-naive patients. A mid-dosing interval therapeutic range between 1,000 and 4,000 ng/mL for efavirenz has been pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Drug Monit
Main Authors: Bednasz, Cindy J., Venuto, Charles S., Ma, Qing, Daar, Eric S., Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Smith, Kimberly Y., Tierney, Camlin, Yang, Yang, Wilding, Gregory E., Morse, Gene D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718358/
https://ncbi.nlm.nih.gov/pubmed/29135907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000443
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados